Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03288831 · ClinicalTrials.gov registry record · NA
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
A NA study of Celiac Disease and Gluten Sensitivity, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03288831 is a NA study of Celiac Disease and Gluten Sensitivity that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,978-participant average among 24 other Celiac Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03288831, a NA study of Celiac Disease and Gluten Sensitivity, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates why people with celiac disease and non-celiac gluten/wheat sensitivity develop rapid onset symptoms within hours of gluten exposure. Half of subjects will be given gluten and half will not.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Gluten
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2018-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03288831
The ClinicalTrials.gov registry entry for NCT03288831 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,978-participant average among 24 other Celiac Disease trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Celiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03288831 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03288831 about?
NCT03288831 is a clinical study titled "Changes in Intestinal Permeability 4 Hours After Gluten Challenge". This study evaluates why people with celiac disease and non-celiac gluten/wheat sensitivity develop rapid onset symptoms within hours of gluten exposure. Half of subjects will be given gluten and half will not.
What is the current status of trial NCT03288831?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-10-10. Estimated completion is 2018-10-30.
What conditions does trial NCT03288831 study?
This clinical trial studies the following conditions: Celiac Disease, Gluten Sensitivity, Immune System and Related Disorders, Wheat Hypersensitivity, Gluten Enteropathy.
What interventions are being tested in trial NCT03288831?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Gluten (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03288831?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03288831 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Immune Responses to Gluten
RECRUITING · NA
-
Gluten Technology and Education for Celiac Health
RECRUITING · NA
-
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
COMPLETED · NA
-
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
COMPLETED · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.